Drug-induced mucosal alterations observed during esophagogastroduodenoscopy

作者：Masaya Iwamuro, Seiji Kawano, Motoyuki Otsuka · 发表于：World Journal of Gastroenterology · 年份：2024 · DOI：10.3748/wjg.v30.i16.2220 · 被引用次数：11 · 研究领域：Potassium and Related Disorders、Pathogenesis and Treatment of Hiccups、Gastroesophageal reflux and treatments

the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet-induced gastric ulcer, immune-related adverse event gastritis, olmesartan-asso-ciated sprue-like enteropathy, pseudomelanosis of the duodenum, and lanthanum deposition in the duodenum. For endoscopists, acquiring accurate knowledge regarding these diverse drug-induced mucosal alterations is crucial not only for the correct diagnosis of these lesions but also for differential diag-nosis of other conditions. This minireview aims to provide essential information on drug-induced mucosal alterations observed on esophagogastroduodenoscopy, along with representative endoscopic images.